ストックスクリーナーアプリを入手
1.22
1.67%
0.02
アフターアワーズ：
1.21
-0.01
-0.82%
前日終値:
$1.20
開ける：
$1.19
24時間の取引高:
586.11K
Relative Volume:
0.47
時価総額：
$159.94M
収益：
$4.35M
当期純損益:
$-45.53M
株価収益率:
-1.1296
EPS:
-1.08
ネットキャッシュフロー:
$-44.79M
1週間 パフォーマンス:
+6.09%
1か月 パフォーマンス:
+2.52%
6か月 パフォーマンス:
+22.31%
1年 パフォーマンス:
-8.27%
1日の値動き範囲:
$1.18
$1.23
1週間の範囲:
$1.15
$1.24
52週間の値動き範囲:
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.22 | 157.32M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 開始されました | BTIG Research | Buy |
| 2021-11-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 開始されました | Needham | Buy |
Lucid Diagnostics Inc (LUCD) 最新ニュース
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Lucid Diagnostics Wins U.S. Department of Veterans Affairs Contract for EsoGuard - marketscreener.com
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Australia
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Lucid Diagnostics rises after winning VA contract for cancer test - TradingView
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Aug Gainers: Is Lucid Diagnostics Inc stock a top performer YTD2025 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Forecast Cut: Is Lucid Diagnostics Inc gaining market share2025 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Why Lucid Diagnostics Inc. stock remains on buy listsWeekly Risk Report & Consistent Profit Trade Alerts - ulpravda.ru
Lucid Diagnostics Insider Ups Holding By 162% During Year - Yahoo Finance UK
How analysts rate Lucid Diagnostics Inc. stock todayShare Buyback & Consistent Profit Alerts - ulpravda.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9% – Here’s Why - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9%Here's Why - MarketBeat
Lucid Diagnostics Inc (LUCD) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.31%
大文字化:
|
ボリューム (24 時間):